Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma

Oncology Nurse Insights Into New Agent

Classes and Research in B-Cell Lymphoma

Practical Issues and Evidence for the Front-Lines of Care

Presented by

Amy Goodrich, NP

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland

TARGET AUDIENCE

This activity has been designed to meet the educational needs of oncology nurses and other clinicians involved in the care of patients with B-cell lymphoma.

EDUCATIONAL OBJECTIVES

Upon completion of this activity, participants will be able to:

• Review updated efficacy and safety data associated with novel agent classes and other emerging therapies in B-cell lymphoma, including BTK,

PI3K, and BCL-2 inhibitors, immunomodulators, antibodies, and CAR-T cell therapy, among others

• Cite dosage, administration strategies, and treatment schedules of novel agent classes for the management of newly diagnosed or refractory/

relapsed B-cell lymphoma

• Apply successful patient educational strategies related to novel therapies and ongoing clinical trials to increase compliance with and adherence to

novel regimens for B-cell lymphoma

• Utilize effective side effect prevention and management strategies related to novel therapies in patients with B-cell malignancies

PROVIDERSHIP, CREDIT & SUPPORT

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and PVI, PeerView Institute for Medical Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Penn State College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Information about CME credit for this activity is available by contacting Penn State at 717-531-6483 or ContinuingEd@hmc.psu.edu. Reference course # G6432A-19-Z.

Nurses

Medical Learning Institute, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Successful completion of this continuing nursing education activity will be awarded 1.0 contact hour(s).

This CME/CNE activity is jointly provided by Penn State College of Medicine and PVI, PeerView Institute for Medical Education; this activity is also co-provided by Medical Learning Institute, Inc.

This activity is supported by educational grants from Bayer HealthCare Pharmaceuticals Inc., Celgene Corporation, Gilead Sciences, Inc., and Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.